(Q39029104)

8 September 2017

1 reference

title

Cytokine networks in neuroinflammation (English)

1 reference

8 September 2017

0 references

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27916979%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Sabine Spath

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27916979%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Joan Goverman

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27916979%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

1

Burkhard Becher

1 reference

8 September 2017

Sabine Spath

2

1 reference

8 September 2017

Joan Goverman

series ordinal

3

1 reference

8 September 2017

5 December 2016

1 reference

Nature Reviews Immunology

8 September 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27916979%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

volume

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27916979%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27916979%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

page(s)

49-59

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27916979%20AND%20SRC:MED&resulttype=core&format=json

TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells

7 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.123

IL-6 controls Th17 immunity in vivo by inhibiting the conversion of conventional T cells into Foxp3+ regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.123

Autoimmune T cell responses in the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.123

Three or more routes for leukocyte migration into the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.123

Immune attack: the role of inflammation in Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.123

Cytokines and CNS development

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.123

Immune proteins in brain development and synaptic plasticity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.123

Influence of LIF and BMP-2 on differentiation and development of glial cells in primary cultures of embryonic rat cerebral hemisphere

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.123

Evidence that embryonic neurons regulate the onset of cortical gliogenesis via cardiotrophin-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.123

Stroma-derived interleukin-34 controls the development and maintenance of langerhans cells and the maintenance of microglia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.123

IL-34 is a tissue-restricted ligand of CSF1R required for the development of Langerhans cells and microglia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.123

Interleukin-34 selectively enhances the neuroprotective effects of microglia to attenuate oligomeric amyloid-β neurotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.123

Fate mapping analysis reveals that adult microglia derive from primitive macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.123

Interleukin-34 restores blood-brain barrier integrity by upregulating tight junction proteins in endothelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.123

Heterogeneity of microglial and perivascular cell populations: insights gained from the facial nucleus paradigm

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.123

The immunology of acute stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.123

Innate and adaptive immune responses in the CNS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.123

Inflammasomes in the CNS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.123

The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.123

A CD36-initiated signaling cascade mediates inflammatory effects of beta-amyloid.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.123

Involvement of microglial receptor for advanced glycation endproducts (RAGE) in Alzheimer's disease: identification of a cellular activation mechanism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.123

Plasma multianalyte profiling in mild cognitive impairment and Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.123

Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.123

Inflammatory cytokine levels correlate with amyloid load in transgenic mouse models of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.123

The glia-derived alarmin IL-33 orchestrates the immune response and promotes recovery following CNS injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.123

How do immune cells support and shape the brain in health, disease, and aging?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.123

Heterogeneity of CNS myeloid cells and their roles in neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.123

Massive gliosis induced by interleukin-6 suppresses Abeta deposition in vivo: evidence against inflammation as a driving force for amyloid deposition

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.123

Hippocampal expression of murine TNFα results in attenuation of amyloid deposition in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.123

Elevated circulating tumor necrosis factor levels in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.123

Differential activation of tumor necrosis factor receptors distinguishes between brains from Alzheimer's disease and non-demented patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.123

Etanercept in Alzheimer disease: A randomized, placebo-controlled, double-blind, phase 2 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.123

Sustained interleukin-1β overexpression exacerbates tau pathology despite reduced amyloid burden in an Alzheimer's mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.123

Blocking IL-1 signaling rescues cognition, attenuates tau pathology, and restores neuronal β-catenin pathway function in an Alzheimer's disease model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.123

Deletion of tumor necrosis factor death receptor inhibits amyloid beta generation and prevents learning and memory deficits in Alzheimer's mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.123

NLRP3 is activated in Alzheimer's disease and contributes to pathology in APP/PS1 mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.123

Inhibition of IL-12/IL-23 signaling reduces Alzheimer's disease-like pathology and cognitive decline.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.123

Cytokine polymorphisms and Alzheimer disease: possible associations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.123

A genetic variation of the inflammatory cytokine interleukin-6 delays the initial onset and reduces the risk for sporadic Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.123

Interleukin-18 promoter polymorphisms and risk of late onset Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.123

Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.123

CSF cytokines/chemokines as biomarkers in neuroinflammatory CNS disorders: A systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.123

APC-derived cytokines and T cell polarization in autoimmune inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.123

Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.123

IL-12 unmasks latent autoimmune disease in resistant mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.123

Experimental autoimmune encephalitis and inflammation in the absence of interleukin-12

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.123

Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.123

Increased IL-23p19 expression in multiple sclerosis lesions and its induction in microglia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.123

IL-6-deficient mice resist myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.123

GM-CSF mediates autoimmunity by enhancing IL-6-dependent Th17 cell development and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.123

Critical regulation of early Th17 cell differentiation by interleukin-1 signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.123

Transcription factors and CD4 T cells seeking identity: masters, minions, setters and spikers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.123

Fate mapping of IL-17-producing T cells in inflammatory responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.123

Different routes of bacterial infection induce long-lived TH1 memory cells and short-lived TH17 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.123

Th17 cells transdifferentiate into regulatory T cells during resolution of inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.123

IL-23 drives a pathogenic T cell population that induces autoimmune inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.123

RORγt drives production of the cytokine GM-CSF in helper T cells, which is essential for the effector phase of autoimmune neuroinflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.123

Therapeutic opportunities of the IL-22-IL-22R1 system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.123

Targeting IL-17 and TH17 cells in chronic inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.123

Interleukin-22 is increased in multiple sclerosis patients and targets astrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.123

Functional interleukin-17 receptor A is expressed in central nervous system glia and upregulated in experimental autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.123

T(H)17 cytokines in autoimmune neuro-inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.123

The role of IL-17 in CNS diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.123

Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.123

Cellular mechanisms of IL-17-induced blood-brain barrier disruption

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.123

Cytokine-regulated neutrophil recruitment is required for brain but not spinal cord inflammation during experimental autoimmune encephalomyelitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.123

Astrocyte-restricted ablation of interleukin-17-induced Act1-mediated signaling ameliorates autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.123

Class II cytokine receptors and their ligands: key antiviral and inflammatory modulators

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.123

The aryl hydrocarbon receptor links TH17-cell-mediated autoimmunity to environmental toxins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.123

Differential influences of the aryl hydrocarbon receptor on Th17 mediated responses in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.123

Treatment of multiple sclerosis with gamma interferon: exacerbations associated with activation of the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.123

Opposing Roles of Interferon-Gamma on Cells of the Central Nervous System in Autoimmune Neuroinflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.123

Immune modulation within the brain: recruitment of inflammatory cells and increased major histocompatibility antigen expression following intracerebral injection of interferon-gamma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.123

A brief history of T(H)17, the first major revision in the T(H)1/T(H)2 hypothesis of T cell-mediated tissue damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.123

The interdependent, overlapping, and differential roles of type I and II IFNs in the pathogenesis of experimental autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.123

Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.123

A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.123

Activation of the STAT signaling pathway can cause expression of caspase 1 and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.123

The integrated stress response prevents demyelination by protecting oligodendrocytes against immune-mediated damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.123

Silencing IFN-γ binding/signaling in astrocytes versus microglia leads to opposite effects on central nervous system autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.123

IFN-γ signaling to astrocytes protects from autoimmune mediated neurological disability

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.123

Interferon-γ safeguards blood-brain barrier during experimental autoimmune encephalomyelitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.123

IFN-γ ameliorates autoimmune encephalomyelitis by limiting myelin lipid peroxidation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.123

IFN-gamma determines distinct clinical outcomes in autoimmune encephalomyelitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.123

Regional CNS responses to IFN-gamma determine lesion localization patterns during EAE pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.123

EAE mediated by a non-IFN-γ/non-IL-17 pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.123

PD-1 immune checkpoint blockade reduces pathology and improves memory in mouse models of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.123

IFN-γ Production by amyloid β-specific Th1 cells promotes microglial activation and increases plaque burden in a mouse model of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.123

Tumor necrosis factor-alpha messenger RNA expression in patients with relapsing-remitting multiple sclerosis is associated with disease activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.123

Synergistic stimulation of MHC class I and IRF-1 gene expression by IFN-gamma and TNF-alpha in oligodendrocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.123

Demyelination occurring during anti-tumor necrosis factor alpha therapy for inflammatory arthritides

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.123

Divergent roles for p55 and p75 tumor necrosis factor receptors in the pathogenesis of MOG(35-55)-induced experimental autoimmune encephalomyelitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.123

Beyond oxidative stress: an immunologist's guide to reactive oxygen species

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.123

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.123

Granulocyte macrophage colony-stimulating factor: a new putative therapeutic target in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.123

The encephalitogenicity of T(H)17 cells is dependent on IL-1- and IL-23-induced production of the cytokine GM-CSF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.123

GM-CSF in Neuroinflammation: Licensing Myeloid Cells for Tissue Damage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.123

Exposure to inflammatory cytokines selectively limits GM-CSF production by induced T regulatory cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.123

The Cytokine GM-CSF Drives the Inflammatory Signature of CCR2+ Monocytes and Licenses Autoimmunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.123

Absence of monocyte chemoattractant protein 1 in mice leads to decreased local macrophage recruitment and antigen-specific T helper cell type 1 immune response in experimental autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.123

CCR2+Ly-6Chi monocytes are crucial for the effector phase of autoimmunity in the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.123

Resistance to experimental autoimmune encephalomyelitis in mice lacking the CC chemokine receptor (CCR)2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.123

CC chemokine receptor 2 is critical for induction of experimental autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.123

Experimental autoimmune encephalomyelitis (EAE) in CCR2(-/-) mice: susceptibility in multiple strains

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.123

Differential roles of microglia and monocytes in the inflamed central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.123

Macrophages in inflammatory multiple sclerosis lesions have an intermediate activation status

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.123

Neuroinflammation in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.123

What is the blood-brain barrier (not)?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.123

The blood-brain barrier and the inflammatory response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.123

What is immune privilege (not)?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.123

Control of autoimmune CNS inflammation by astrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.123

Astrocyte Depletion Impairs Redox Homeostasis and Triggers Neuronal Loss in the Adult CNS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.123

Origin, fate and dynamics of macrophages at central nervous system interfaces

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.123

Localizing central nervous system immune surveillance: meningeal antigen-presenting cells activate T cells during experimental autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.123

Dendritic cells permit immune invasion of the CNS in an animal model of multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.123

Dendritic cells, monocytes and macrophages: a unified nomenclature based on ontogeny

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.123

Differentiation and function of mouse monocyte-derived dendritic cells in steady state and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.123

How does the brain limit the severity of inflammation and tissue injury during bacterial meningitis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.123

Vaccination against autoimmune encephalomyelitis with T-lymphocite line cells reactive against myelin basic protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.123

The Role of gp130 in cerebral cortical development: in vivo functional analysis in a mouse exo utero system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.123

CNTF/LIF/gp130 receptor complex signaling maintains a VZ precursor differentiation gradient in the developing ventral forebrain

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.123

Chronic interleukin-1beta expression in mouse brain leads to leukocyte infiltration and neutrophil-independent blood brain barrier permeability without overt neurodegeneration

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.123

IL-22 is expressed by Th17 cells in an IL-23-dependent fashion, but not required for the development of autoimmune encephalomyelitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.123

IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.123

Direct injection of cytokines into the spinal cord causes autoimmune encephalomyelitis-like inflammation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.123

Indolamine 2,3-dioxygenase is expressed in the CNS and down-regulates autoimmune inflammation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.123

Increased production of interferon gamma and tumor necrosis factor precedes clinical manifestation in multiple sclerosis: do cytokines trigger off exacerbations?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.123

Apoptosis of Oligodendrocytes via Fas and TNF-R1 Is a Key Event in the Induction of Experimental Autoimmune Encephalomyelitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.123

Autoantigen specific T cells inhibit glutamate uptake in astrocytes by decreasing expression of astrocytic glutamate transporter GLAST: a mechanism mediated by tumor necrosis factor-alpha

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.123

Tumor necrosis factor-alpha enhances interferon-gamma-mediated class II antigen expression on astrocytes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.123

Severity of symptoms and demyelination in MOG-induced EAE depends on TNFR1

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.123

Neutrophils in multiple sclerosis are characterized by a primed phenotype

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.123

The contribution of neutrophils to CNS autoimmunity.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.123

Microglia in Health and Disease.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI.2016.123

Cytokine-induced expression of vascular cell adhesion molecule-1 (VCAM-1) by astrocytes and astrocytoma cell lines

31 March 2020

1 reference

12 December 2020

Microglia, Alzheimer's disease, and complement

1 reference

12 December 2020

Association of interleukin-1 gene polymorphisms with Alzheimer's disease

1 reference

12 December 2020

Role of IFN-gamma in induction of Foxp3 and conversion of CD4+ CD25- T cells to CD4+ Tregs

1 reference

12 December 2020

Studies on the problem of corneal homografts

1 reference

12 December 2020

IL-17A and IL-17F do not contribute vitally to autoimmune neuro-inflammation in mice

1 reference

12 December 2020

Enhancement of experimental allergic encephalomyelitis in mice by antibodies against IFN-gamma

1 reference

12 December 2020

TNF neutralization in MS: results of a randomized, placebo-controlled multicenter study. The Lenercept Multiple Sclerosis Study Group and The University of British Columbia MS/MRI Analysis Group

1 reference

12 December 2020

Identifiers

DOI

10.1038/NRI.2016.123

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27916979%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

1 reference